Li Mei, Jin Yuanhui, Hu Jiangjian
Department of Ophthalmology, Dongyang People's Hospital, Jinhua, 322100, China.
BMC Ophthalmol. 2025 Feb 27;25(1):100. doi: 10.1186/s12886-025-03927-x.
This study aims to evaluate the effectiveness and safety of phacoemulsification cataract extraction with intraocular lens implantation (PEI) combined with Goniosynechialysis (GSL), Goni-otomy (GT), and PEI combined with Trabeculectomy (TRAB), in managing mid to late-stage Primary Angle-Closure Glaucoma (PACG) combined with cataract.
A retrospective analysis was conducted on 42 patients (54 eyes) with mid to late-stage PACG combined with cataracts, who were previously treated at Dongyang People's Hospital from December 3, 2020, to November 30, 2023. Among them, 16 (24 eyes) underwent PEI-GSL-GT, and 26 (30 eyes) underwent PEI-TRAB. After minimum of 6 months of postoperative follow-up, observations were made on intraocular pressure (IOP), best-corrected visual acuity (BCVA), use of antiglaucoma medications, and complications for both surgical procedures.
Postoperative BCVA improved significantly in both groups. In the PEI-GSL-GT group, IOP decreased by 26% (from 17.75 to 13.13 mmHg); in the PEI-TRAB group, it decreased by 14.5% (from 17.87 to 15.27 mmHg). At the 6-month follow-up, IOP was significantly lower in the PEI-GSL-GT group compared to the PEI-TRAB group. The number of patients using antiglaucoma medications decreased significantly in both groups. By the 6-month follow-up, no patients in the PEI-GSL-GT group were using antiglaucoma medications.
PEI-GSL-GT is more effective than PEI-TRAB in lowering IOP in patients with mid to late-stage PACG, potentially reducing or discontinuing postoperative antiglaucoma medications, decreasing postoperative complications, and improving visual acuity.
本研究旨在评估白内障超声乳化吸除联合人工晶状体植入术(PEI)联合房角粘连分离术(GSL)、房角切开术(GT)以及PEI联合小梁切除术(TRAB)治疗中晚期原发性闭角型青光眼(PACG)合并白内障的有效性和安全性。
对2020年12月3日至2023年11月30日期间在东阳人民医院接受治疗的42例(54只眼)中晚期PACG合并白内障患者进行回顾性分析。其中,16例(24只眼)接受了PEI-GSL-GT手术,26例(30只眼)接受了PEI-TRAB手术。术后至少随访6个月,观察两组手术的眼压(IOP)、最佳矫正视力(BCVA)、抗青光眼药物使用情况及并发症。
两组术后BCVA均显著提高。PEI-GSL-GT组眼压下降26%(从17.75 mmHg降至13.13 mmHg);PEI-TRAB组眼压下降14.5%(从17.87 mmHg降至15.27 mmHg)。在6个月随访时,PEI-GSL-GT组眼压显著低于PEI-TRAB组。两组使用抗青光眼药物的患者数量均显著减少。到6个月随访时,PEI-GSL-GT组无患者使用抗青光眼药物。
在降低中晚期PACG患者眼压方面PEI-GSL-GT比PEI-TRAB更有效,可能减少或停用术后抗青光眼药物,降低术后并发症,并提高视力。